BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1700 related articles for article (PubMed ID: 26631930)

  • 1. Tau in physiology and pathology.
    Wang Y; Mandelkow E
    Nat Rev Neurosci; 2016 Jan; 17(1):5-21. PubMed ID: 26631930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies.
    Venkatramani A; Panda D
    Int J Biol Macromol; 2019 Jul; 133():473-483. PubMed ID: 31004638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tauopathies.
    Hernández F; Avila J
    Cell Mol Life Sci; 2007 Sep; 64(17):2219-33. PubMed ID: 17604998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further understanding of tau phosphorylation: implications for therapy.
    Medina M; Avila J
    Expert Rev Neurother; 2015 Jan; 15(1):115-22. PubMed ID: 25555397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tau and Axonal Transport Misregulation in Tauopathies.
    Combs B; Mueller RL; Morfini G; Brady ST; Kanaan NM
    Adv Exp Med Biol; 2019; 1184():81-95. PubMed ID: 32096030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?
    Alavi Naini SM; Soussi-Yanicostas N
    Oxid Med Cell Longev; 2015; 2015():151979. PubMed ID: 26576216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein.
    Feuillette S; Miguel L; Frébourg T; Campion D; Lecourtois M
    J Neurochem; 2010 May; 113(4):895-903. PubMed ID: 20193038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Dual Pathogenic Mechanism Links Tau Acetylation to Sporadic Tauopathy.
    Trzeciakiewicz H; Tseng JH; Wander CM; Madden V; Tripathy A; Yuan CX; Cohen TJ
    Sci Rep; 2017 Mar; 7():44102. PubMed ID: 28287136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycation alter the process of Tau phosphorylation to change Tau isoforms aggregation property.
    Liu K; Liu Y; Li L; Qin P; Iqbal J; Deng Y; Qing H
    Biochim Biophys Acta; 2016 Feb; 1862(2):192-201. PubMed ID: 26655600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models.
    Hannan SB; Dräger NM; Rasse TM; Voigt A; Jahn TR
    J Neurochem; 2016 Apr; 137(1):12-25. PubMed ID: 26756400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau and tauopathies.
    Arendt T; Stieler JT; Holzer M
    Brain Res Bull; 2016 Sep; 126(Pt 3):238-292. PubMed ID: 27615390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The microtubule-associated protein tau in neurodegenerative diseases. Tauopathies].
    Sánchez MP; Alvarez-Tallada V; Avila J
    Rev Neurol; 2001 Jul 16-31; 33(2):169-77. PubMed ID: 11562878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief update on different roles of tau in neurodegeneration.
    Ittner A; Ke YD; van Eersel J; Gladbach A; Götz J; Ittner LM
    IUBMB Life; 2011 Jul; 63(7):495-502. PubMed ID: 21698753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau liquid-liquid phase separation: At the crossroads of tau physiology and tauopathy.
    Islam M; Shen F; Regmi D; Petersen K; Karim MRU; Du D
    J Cell Physiol; 2024 Jun; 239(6):e30853. PubMed ID: 35980344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinesin-1 transport reductions enhance human tau hyperphosphorylation, aggregation and neurodegeneration in animal models of tauopathies.
    Falzone TL; Gunawardena S; McCleary D; Reis GF; Goldstein LS
    Hum Mol Genet; 2010 Nov; 19(22):4399-408. PubMed ID: 20817925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The physiology and pathology of microtubule-associated protein tau.
    Wang JZ; Gao X; Wang ZH
    Essays Biochem; 2014; 56():111-23. PubMed ID: 25131590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of tau protein in health and disease.
    Guo T; Noble W; Hanger DP
    Acta Neuropathol; 2017 May; 133(5):665-704. PubMed ID: 28386764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryonic stem cell-based modeling of tau pathology in human neurons.
    Mertens J; Stüber K; Poppe D; Doerr J; Ladewig J; Brüstle O; Koch P
    Am J Pathol; 2013 May; 182(5):1769-79. PubMed ID: 23499461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontotemporal dementia with tau pathology.
    Gasparini L; Terni B; Spillantini MG
    Neurodegener Dis; 2007; 4(2-3):236-53. PubMed ID: 17596718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau protein modifications and interactions: their role in function and dysfunction.
    Mietelska-Porowska A; Wasik U; Goras M; Filipek A; Niewiadomska G
    Int J Mol Sci; 2014 Mar; 15(3):4671-713. PubMed ID: 24646911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 85.